leading glp-1 treatments for diabetes 2025 GLP-1-based therapies diabetes, obesity and beyond GLP-1 Pipeline Update: August 2025

Understanding Fatty Liver Disease Non-alcoholic fatty liver disease (NAFLD) is a broad term that encompasses liver conditions that are not caused by excessive alcohol consumption

Helps patients find supply There is an incredible community forming online of patients trying to help other patients find medication

Julius Few, MD, a plastic surgeon and founder of The Few Institute in Chicago, noticed his facelift patients who were on GLP-1s had skin like worn-out rubber bands or old putty, his words

Tirzepatide for Weight Loss in St

Semaglutide, which is the most potent pure GLP-1 RA available, has produced weight loss of up to 17% to 20% in clinical trials designed to assess its effect on weight, says Dr